Hacker News new | ask | show | jobs
by erkkie 2993 days ago
This and just the economics of it. It makes sense to sell at what price the market can handle, as long as it's above direct production cost (which it is). It's basically cheap marketing that happens to align with patient interests.

edit: A lot of it is also politics with the host country. India for example has said it will produce cheap generics of drugs if it wants to, ignoring patents: https://www.forbes.com/sites/johnlamattina/2013/04/08/indias...